The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for belzutifan (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
belzutifan
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate-release tablet
Indication
Treatment of von Hippel-Lindau (VHL) disease
Therapeutic area
Oncology